1. Recurrent Malignant Glioma- Pipeline Review, H2 2016 Phone No.: +1 (214) 884-6817 Email id: sales@orbisresearch.com

2. Recurrent Malignant Glioma-Pipeline Review, H2 2016 The Recurrent Malignant Glioma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Recurrent Malignant Glioma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II and Phase I stages are 2 and 2 respectively. Similarly, the Universities portfolio in Phase II and Phase I stages comprises 3 and 2 molecules, respectively. Request a sample of this report @ http://www.orbisresearch.com/contacts/request- sample/172623.http://www.orbisresearch.com/contacts/request- sample/172623 Companies Mentioned: 2-BBB Medicines BV AbbVie Inc DNAtrix Inc GtreeBNT Co Ltd Phone No.: +1 (214) 884-6817 Email id: sales@orbisresearch.com

3. About Us: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors accross the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients. Contact Information: 4144N Central Expressway, Suite 600, Dallas, Texas - 75204, U.S.A. Phone No.: +1 (214) 884-6817 enquiry@orbisresearch.com sales@orbisresearch.com Phone No.: +1 (214) 884-6817 Email id: sales@orbisresearch.com Recurrent Malignant Glioma-Pipeline Review, H2 2016